Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A very important seminar sponsored by WHO and FDA took place in Bethesda in 2007. The evaluation of the link between surrogate end points and effective ones in the production of pre pandemic vaccines was the topic. If the in vitro titre of anti HI corresponds to a real protection or which is the quantitative threshold of efficacy were questions without sure answers. Same problems for H5N1. So maybe "More is better" isn't enough.

Type

Journal article

Journal

Quaderni ACP

Publication Date

01/03/2008

Volume

15